结直肠腺瘤患者中APC嵌合体的患病率及后果
本研究对541例广泛息肉病表型患者行靶向二代测序分析APC嵌合体,总检出率为9.4%。符合国家遗传性息肉病检测指南范围者检出率为14.3%(46/322),不符合者为2.3%(5/219)。作者建议对特定腺瘤负荷且胚系致病性变异阴性的患者进行APC嵌合体检测,并对嵌合体患者提供定期结肠镜和至少一次胃十二指肠镜检查。
要点
- APC嵌合体在广泛息肉病表型患者中总检出率为9.4%。
- 符合国家指南检测范围者检出率14.3%,不符合者为2.3%。
- ≥20个腺瘤(60岁前)或≥30个腺瘤(70岁前)者检出率≥10%。
核心结论
- 建议对胚系致病性变异阴性且满足≥20个腺瘤(60岁前)或≥30个腺瘤(70岁前)的患者进行APC嵌合体检测。
- APC嵌合体患者应接受定期结肠镜和至少一次胃十二指肠镜检查,随访频率基于发现。
- 应考虑为APC嵌合体患者的子女提供胚系检测。
研究设计与样本
- 研究采用靶向二代测序分析541例具有广泛息肉病表型患者的APC嵌合体。
主要发现
- 总APC嵌合体检出率为9.4%。
- 符合国家遗传性息肉病检测指南范围的患者检出率为14.3%(46/322)。
- 不符合国家指南范围的患者检出率为2.3%(5/219)。
- 在60岁前≥20个腺瘤或70岁前≥30个腺瘤的患者中,检出率≥10%。
- 34例接受食管胃十二指肠镜检查的嵌合体患者中,26%诊断为胃十二指肠息肉。
关键数值与推荐
- 国家遗传性息肉病检测指南范围:60岁前≥10个腺瘤或70岁前≥20个腺瘤。
- 推荐检测条件:60岁前≥20个腺瘤或70岁前≥30个腺瘤且胚系致病性变异阴性。
- 在2例接受检测的患者中,1例的精液中检测到嵌合变异,但本队列中无子女遗传该嵌合变异。
临床怎么用
- 对符合推荐条件的患者应进行APC嵌合体检测。
- APC嵌合体患者应定期结肠镜检查和至少一次胃十二指肠镜检查。
- 应考虑对APC嵌合体患者的子女进行胚系检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: A substantial proportion of patients with adenomatous polyposis have no germline pathogenic variant in APC. The aim of this study was to determine the prevalence of APC mosaicism in these patients with unexplained polyposis and to draft guidelines for APC mosaicism testing and surveillance. METHODS: APC mosaicism was analyzed by targeted next-generation sequencing in 541 patients with a broad spectrum of polyposis phenotypes. RESULTS: The rate of APC mosaicism was 9.4%. This rate was 14.3% (46 of 322) in patients who met the scope of national hereditary polyposis testing guidelines (≥10 adenomas before the age of 60 or with ≥20 adenomas before the age of 70). In patients who did not meet the scope of national guidelines, the detection rate was 2.3% (5 of 219). In patients with ≥20 adenomas before the age of 60 or ≥30 adenomas before the age of 70, the detection rate was ≥10%. Of 34 mosaic patients who underwent an esophagogastroduodenoscopy, 26% were diagnosed with gastroduodenal polyps. In 1 of the 2 patients tested, the mosaic variant was detected in semen, but none of the children tested in this cohort inherited the mosaic variant. CONCLUSIONS: We recommend APC mosaicism testing at least in patients negative for germline pathogenic variants with (1) ≥20 adenomas before the age of 60 or (2) ≥30 adenomas before the age of 70. Regular colonoscopy and at least 1 gastroduodenoscopy should be offered to APC mosaic patients, with frequency of follow-up based on findings. Offering germline testing for offspring should be considered.
引用
- Terlouw D, Suerink M, Buitelaar Y, et al. Prevalence and Consequences of APC Mosaicism in Patients With Colorectal Adenomas. Gastroenterology. 2026. PMID: 41801175. doi:10.1053/j.gastro.2025.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。